[1] SUNG Y H, JUNG J H, RYANG S H, et al. Clinical significance of national institutes of health classification in patients with chronic prostatitis/chronic pelvic pain syndrome
[J]. Korean J Urol, 2014, 55(4): 276-280.

[2] KHATTAK A S, RAISON N, HAWAZIE A, et al. Contemporary Management of Chronic Prostatitis
[J]. Cureus, 2021, 13(12): e20243.

[3] ARORA H C, ENG C, SHOSKES D A. Gut microbiome and chronic prostatitis/chronic pelvic pain syndrome
[J]. Ann Transl Med, 2017, 5(2): 30.

[4] CHEN R, NICKEL J C. Acupuncture ameliorates symptoms in men with chronic prostatitis/chronic pelvic pain syndrome
[J]. Urology, 2003, 61(6): 1156-1159; discussion 9.

[5] LUPO F, INGERSOLL M A. Is bacterial prostatitis a urinary tract infection?
[J]. Nat Rev Urol, 2019, 16(4): 203-204.

[6] REES J, ABRAHAMS M, DOBLE A, et al. Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline
[J]. BJU International, 2015, 116(4): 509-525.

[7] KONKOL Y, VUORIKOSKI H, STRENG T, et al. Characterization of a model of prostatic diseases and obstructive voiding induced by sex hormone imbalance in the Wistar and Noble rats
[J]. Transl Androl Urol, 2019, 8(Suppl 1): S45-S57.

[8] LIU Y, MIKRANI R, XIE D, et al. Chronic prostatitis/chronic pelvic pain syndrome and prostate cancer: study of immune cells and cytokines
[J]. Fundam Clin Pharmacol, 2020, 34(2): 160-172.

[9] XIANG H, ZHANG T, AL-DANAKH A, et al. Neuromodulation in Chronic Pelvic Pain: A Narrative Review
[J]. Pain Ther, 2022, 11(3): 789-816.

[10] BAI J, WANG S, LIU J, et al. Characterization of circulating CD4+CD25high regulatory T cells in men with chronic prostatitis/chronic pelvic pain syndrome
[J]. Urology, 2010, 75(4): 938-942.

[11] KRSMANOVIC A, TRIPP D A, NICKEL J C, et al. Psychosocial mechanisms of the pain and quality of life relationship for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
[J]. Can Urol Assoc J, 2014, 8(11-12): 403-408.

[12] WANG G C, HUANG T R, HU Y Y, et al. Corpus cavernosum smooth muscle cell dysfunction and phenotype transformation are related to erectile dysfunction in prostatitis rats with chronic prostatitis/ chronic pelvic pain syndrome
[J]. J Inflamm (Lond), 2020, 17.

[13] WU Y, JIANG H, TAN M, et al. Screening for chronic prostatitis pathogens using high-throughput next- generation sequencing
[J]. Prostate, 2020, 80(7): 577-587.

[14] SHOSKES D A, ALTEMUS J, POLACKWICH A S, et al. The Urinary Microbiome Differs Significantly Between Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Controls as Well as Between Patients With Different Clinical Phenotypes
[J]. Urology, 2016, 92: 26-32.

[15] POLACKWICH A S, SHOSKES D A. Chronic prostatitis/chronic pelvic pain syndrome: a review of evaluation and therapy
[J]. Prostate Cancer Prostatic Dis, 2016, 19(2): 132-8.

[16] APPIYA SANTHARAM M, KHAN F U, NAVEED M, et al. Interventions to chronic prostatitis/Chronic pelvic pain syndrome treatment. Where are we standing and what's next?
[J]. European Journal of Pharmacology, 2019, 857

[17] FALL M, BARANOWSKI A P, ELNEIL S, et al. EAU guidelines on chronic pelvic pain
[J]. Eur Urol, 2010, 57(1): 35-48.

[18] MAGISTRO G, WAGENLEHNER F M, GRABE M, et al. Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome
[J]. Eur Urol, 2016, 69(2): 286-297.

[19] Yellepeddi V K, Radhakrishnan J, Radhakrishnan R. Penetration and pharmacokinetics of non-steroidal anti-inflammatory drugs in rat prostate tissue
[J]. Prostate, 2018, 78(2): 80-85.

[20] LI H, HUNG A, YANG A W H. A Classic Herbal Formula Danggui Beimu Kushen Wan for Chronic Prostatitis: From Traditional Knowledge to Scientific Exploration
[J]. Evid Based Complement Alternat Med, 2018, 2018.

[21] LUAN Y, SUN C, WANG J, et al. Baicalin attenuates myocardial ischemia-reperfusion injury through Akt/ NF-kappaB pathway
[J]. J Cell Biochem, 2019, 120(3): 3212-3219.

[22] LONG Y, XIANG Y, LIU S, et al. Baicalin Liposome Alleviates Lipopolysaccharide-Induced Acute Lung Injury in Mice via Inhibiting TLR4/JNK/ERK/NF-kappaB Pathway
[J]. Mediators Inflamm, 2020, 2020(8414062.

[23] MENG L-Q, YANG F-Y, WANG M-S, et al. Quercetin protects against chronic prostatitis in rat model through NF-κB and MAPK signaling pathways
[J]. The Prostate, 2018, 78(11): 790-800.

[24] ZHAO Q, YANG F, MENG L, et al. Lycopene attenuates chronic prostatitis/chronic pelvic pain syndrome by inhibiting oxidative stress and inflammation via the interaction of NF-kappaB, MAPKs, and Nrf2 signaling pathways in rats
[J]. Andrology, 2020, 8(3): 747-755.

[25] FRANCO J V A, TURK T, JUNG J H, et al. Non-pharmacological interventions for treating chronic prostatitis/ chronic pelvic pain syndrome: a Cochrane systematic review
[J]. BJU International, 2019, 124(2): 197-208.

[26] GUU S-J, LIU C-C, JUAN Y-S, et al. The 12-month follow-up of the low-intensity extracorporeal shockwave therapy in the treatment of patients with chronic pelvic pain syndrome refractory to 3-As medications
[J]. The Aging Male, 2019, 23(5): 793-800.

[27] Zhang Z-X, Zhang D, Yu X-T, et al. Efficacy of Radial Extracorporeal Shock Wave Therapy for Chronic Pelvic Pain Syndrome: A Nonrandomized Controlled Trial
[J]. American Journal of Men's Health, 2018, 13(1). 

[28] QIN Z, WU J, XU C, et al. Long-term effects of acupuncture for chronic prostatitis/chronic pelvic pain syndrome: systematic review and single-arm meta- analyses
[J]. Annals of Translational Medicine, 2019, 7(6): 113.

[29] ZHENG J, HU R, YANG Y, et al. Antibiotic-loaded reactive oxygen species-responsive nanomedicine for effective management of chronic bacterial prostatitis
[J]. Acta Biomater, 2022, 143: 471-486.

[30] GAO Y, LIU K, ZHANG Y, et al. Hyaluronic acid-modified curcumin-copper complex nano delivery system for rapid healing of bacterial prostatitis
[J]. Carbohydr Polym, 2023, 310:120668.